nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—CYP3A4—Ifosfamide—testicular cancer	0.0386	0.272	CbGbCtD
Bisoprolol—CYP2D6—Vinblastine—testicular cancer	0.0322	0.227	CbGbCtD
Bisoprolol—CYP3A4—Vinblastine—testicular cancer	0.0205	0.144	CbGbCtD
Bisoprolol—CYP2D6—Doxorubicin—testicular cancer	0.0198	0.139	CbGbCtD
Bisoprolol—CYP3A4—Etoposide—testicular cancer	0.0184	0.13	CbGbCtD
Bisoprolol—CYP3A4—Doxorubicin—testicular cancer	0.0126	0.0886	CbGbCtD
Bisoprolol—Drowsiness—Epirubicin—testicular cancer	0.000743	0.000866	CcSEcCtD
Bisoprolol—Vomiting—Dactinomycin—testicular cancer	0.000742	0.000865	CcSEcCtD
Bisoprolol—Bronchitis—Doxorubicin—testicular cancer	0.000741	0.000864	CcSEcCtD
Bisoprolol—Agranulocytosis—Methotrexate—testicular cancer	0.000741	0.000863	CcSEcCtD
Bisoprolol—Rash—Dactinomycin—testicular cancer	0.000736	0.000858	CcSEcCtD
Bisoprolol—Diarrhoea—Ifosfamide—testicular cancer	0.000732	0.000853	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Etoposide—testicular cancer	0.00073	0.00085	CcSEcCtD
Bisoprolol—Body temperature increased—Cisplatin—testicular cancer	0.000729	0.00085	CcSEcCtD
Bisoprolol—Fatigue—Etoposide—testicular cancer	0.000729	0.000849	CcSEcCtD
Bisoprolol—Pain—Etoposide—testicular cancer	0.000723	0.000842	CcSEcCtD
Bisoprolol—Constipation—Etoposide—testicular cancer	0.000723	0.000842	CcSEcCtD
Bisoprolol—Urinary tract infection—Epirubicin—testicular cancer	0.000722	0.000842	CcSEcCtD
Bisoprolol—Conjunctivitis—Epirubicin—testicular cancer	0.000722	0.000842	CcSEcCtD
Bisoprolol—Hepatitis—Methotrexate—testicular cancer	0.000713	0.000831	CcSEcCtD
Bisoprolol—Sweating—Epirubicin—testicular cancer	0.000712	0.00083	CcSEcCtD
Bisoprolol—Dizziness—Ifosfamide—testicular cancer	0.000708	0.000825	CcSEcCtD
Bisoprolol—Pharyngitis—Methotrexate—testicular cancer	0.000707	0.000824	CcSEcCtD
Bisoprolol—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000704	0.00082	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Epirubicin—testicular cancer	0.000703	0.000819	CcSEcCtD
Bisoprolol—Weight increased—Doxorubicin—testicular cancer	0.000702	0.000818	CcSEcCtD
Bisoprolol—Sinusitis—Epirubicin—testicular cancer	0.000697	0.000812	CcSEcCtD
Bisoprolol—Feeling abnormal—Etoposide—testicular cancer	0.000696	0.000812	CcSEcCtD
Bisoprolol—Nausea—Dactinomycin—testicular cancer	0.000694	0.000808	CcSEcCtD
Bisoprolol—Agranulocytosis—Epirubicin—testicular cancer	0.000693	0.000808	CcSEcCtD
Bisoprolol—Pneumonia—Doxorubicin—testicular cancer	0.000691	0.000806	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Etoposide—testicular cancer	0.000691	0.000806	CcSEcCtD
Bisoprolol—Drowsiness—Doxorubicin—testicular cancer	0.000687	0.000801	CcSEcCtD
Bisoprolol—Visual impairment—Methotrexate—testicular cancer	0.000687	0.0008	CcSEcCtD
Bisoprolol—Vomiting—Ifosfamide—testicular cancer	0.00068	0.000793	CcSEcCtD
Bisoprolol—Hypersensitivity—Cisplatin—testicular cancer	0.00068	0.000792	CcSEcCtD
Bisoprolol—Bradycardia—Epirubicin—testicular cancer	0.000679	0.000791	CcSEcCtD
Bisoprolol—Rash—Ifosfamide—testicular cancer	0.000675	0.000786	CcSEcCtD
Bisoprolol—Dermatitis—Ifosfamide—testicular cancer	0.000674	0.000786	CcSEcCtD
Bisoprolol—Urticaria—Etoposide—testicular cancer	0.000671	0.000783	CcSEcCtD
Bisoprolol—Rhinitis—Epirubicin—testicular cancer	0.000669	0.000779	CcSEcCtD
Bisoprolol—Body temperature increased—Etoposide—testicular cancer	0.000668	0.000779	CcSEcCtD
Bisoprolol—Abdominal pain—Etoposide—testicular cancer	0.000668	0.000779	CcSEcCtD
Bisoprolol—Conjunctivitis—Doxorubicin—testicular cancer	0.000668	0.000779	CcSEcCtD
Bisoprolol—Urinary tract infection—Doxorubicin—testicular cancer	0.000668	0.000779	CcSEcCtD
Bisoprolol—Hepatitis—Epirubicin—testicular cancer	0.000667	0.000777	CcSEcCtD
Bisoprolol—Eye disorder—Methotrexate—testicular cancer	0.000666	0.000776	CcSEcCtD
Bisoprolol—Tinnitus—Methotrexate—testicular cancer	0.000664	0.000774	CcSEcCtD
Bisoprolol—Hypoaesthesia—Epirubicin—testicular cancer	0.000663	0.000773	CcSEcCtD
Bisoprolol—Asthenia—Cisplatin—testicular cancer	0.000662	0.000771	CcSEcCtD
Bisoprolol—Pharyngitis—Epirubicin—testicular cancer	0.000662	0.000771	CcSEcCtD
Bisoprolol—Cardiac disorder—Methotrexate—testicular cancer	0.000661	0.000771	CcSEcCtD
Bisoprolol—Sweating—Doxorubicin—testicular cancer	0.000659	0.000768	CcSEcCtD
Bisoprolol—Oedema peripheral—Epirubicin—testicular cancer	0.000657	0.000766	CcSEcCtD
Bisoprolol—Connective tissue disorder—Epirubicin—testicular cancer	0.000655	0.000764	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00065	0.000758	CcSEcCtD
Bisoprolol—Angiopathy—Methotrexate—testicular cancer	0.000646	0.000754	CcSEcCtD
Bisoprolol—Sinusitis—Doxorubicin—testicular cancer	0.000645	0.000752	CcSEcCtD
Bisoprolol—Visual impairment—Epirubicin—testicular cancer	0.000643	0.000749	CcSEcCtD
Bisoprolol—Mediastinal disorder—Methotrexate—testicular cancer	0.000642	0.000749	CcSEcCtD
Bisoprolol—Agranulocytosis—Doxorubicin—testicular cancer	0.000641	0.000748	CcSEcCtD
Bisoprolol—Nausea—Ifosfamide—testicular cancer	0.000636	0.000741	CcSEcCtD
Bisoprolol—Diarrhoea—Cisplatin—testicular cancer	0.000631	0.000736	CcSEcCtD
Bisoprolol—Alopecia—Methotrexate—testicular cancer	0.00063	0.000734	CcSEcCtD
Bisoprolol—Bradycardia—Doxorubicin—testicular cancer	0.000628	0.000732	CcSEcCtD
Bisoprolol—Mental disorder—Methotrexate—testicular cancer	0.000624	0.000728	CcSEcCtD
Bisoprolol—Eye disorder—Epirubicin—testicular cancer	0.000623	0.000726	CcSEcCtD
Bisoprolol—Hypersensitivity—Etoposide—testicular cancer	0.000623	0.000726	CcSEcCtD
Bisoprolol—Tinnitus—Epirubicin—testicular cancer	0.000622	0.000725	CcSEcCtD
Bisoprolol—Erythema—Methotrexate—testicular cancer	0.00062	0.000723	CcSEcCtD
Bisoprolol—Flushing—Epirubicin—testicular cancer	0.000619	0.000721	CcSEcCtD
Bisoprolol—Cardiac disorder—Epirubicin—testicular cancer	0.000619	0.000721	CcSEcCtD
Bisoprolol—Rhinitis—Doxorubicin—testicular cancer	0.000619	0.000721	CcSEcCtD
Bisoprolol—Hepatitis—Doxorubicin—testicular cancer	0.000617	0.000719	CcSEcCtD
Bisoprolol—Hypoaesthesia—Doxorubicin—testicular cancer	0.000614	0.000716	CcSEcCtD
Bisoprolol—Pharyngitis—Doxorubicin—testicular cancer	0.000612	0.000714	CcSEcCtD
Bisoprolol—Oedema peripheral—Doxorubicin—testicular cancer	0.000608	0.000708	CcSEcCtD
Bisoprolol—Dysgeusia—Methotrexate—testicular cancer	0.000607	0.000708	CcSEcCtD
Bisoprolol—Asthenia—Etoposide—testicular cancer	0.000606	0.000707	CcSEcCtD
Bisoprolol—Connective tissue disorder—Doxorubicin—testicular cancer	0.000606	0.000707	CcSEcCtD
Bisoprolol—Angiopathy—Epirubicin—testicular cancer	0.000605	0.000705	CcSEcCtD
Bisoprolol—Mediastinal disorder—Epirubicin—testicular cancer	0.000601	0.0007	CcSEcCtD
Bisoprolol—Back pain—Methotrexate—testicular cancer	0.0006	0.000699	CcSEcCtD
Bisoprolol—Pruritus—Etoposide—testicular cancer	0.000598	0.000697	CcSEcCtD
Bisoprolol—Arrhythmia—Epirubicin—testicular cancer	0.000596	0.000694	CcSEcCtD
Bisoprolol—Visual impairment—Doxorubicin—testicular cancer	0.000595	0.000693	CcSEcCtD
Bisoprolol—Alopecia—Epirubicin—testicular cancer	0.000589	0.000687	CcSEcCtD
Bisoprolol—Vomiting—Cisplatin—testicular cancer	0.000587	0.000684	CcSEcCtD
Bisoprolol—Mental disorder—Epirubicin—testicular cancer	0.000584	0.000681	CcSEcCtD
Bisoprolol—Rash—Cisplatin—testicular cancer	0.000582	0.000678	CcSEcCtD
Bisoprolol—Dermatitis—Cisplatin—testicular cancer	0.000581	0.000677	CcSEcCtD
Bisoprolol—Erythema—Epirubicin—testicular cancer	0.00058	0.000677	CcSEcCtD
Bisoprolol—Diarrhoea—Etoposide—testicular cancer	0.000578	0.000674	CcSEcCtD
Bisoprolol—Eye disorder—Doxorubicin—testicular cancer	0.000577	0.000672	CcSEcCtD
Bisoprolol—Ill-defined disorder—Methotrexate—testicular cancer	0.000576	0.000671	CcSEcCtD
Bisoprolol—Tinnitus—Doxorubicin—testicular cancer	0.000575	0.000671	CcSEcCtD
Bisoprolol—Flushing—Doxorubicin—testicular cancer	0.000573	0.000667	CcSEcCtD
Bisoprolol—Cardiac disorder—Doxorubicin—testicular cancer	0.000573	0.000667	CcSEcCtD
Bisoprolol—Dysgeusia—Epirubicin—testicular cancer	0.000568	0.000663	CcSEcCtD
Bisoprolol—Back pain—Epirubicin—testicular cancer	0.000562	0.000654	CcSEcCtD
Bisoprolol—Angiopathy—Doxorubicin—testicular cancer	0.00056	0.000652	CcSEcCtD
Bisoprolol—Malaise—Methotrexate—testicular cancer	0.000559	0.000652	CcSEcCtD
Bisoprolol—Dizziness—Etoposide—testicular cancer	0.000559	0.000651	CcSEcCtD
Bisoprolol—Muscle spasms—Epirubicin—testicular cancer	0.000558	0.00065	CcSEcCtD
Bisoprolol—Vertigo—Methotrexate—testicular cancer	0.000557	0.00065	CcSEcCtD
Bisoprolol—Mediastinal disorder—Doxorubicin—testicular cancer	0.000556	0.000648	CcSEcCtD
Bisoprolol—Arrhythmia—Doxorubicin—testicular cancer	0.000551	0.000642	CcSEcCtD
Bisoprolol—Nausea—Cisplatin—testicular cancer	0.000548	0.000639	CcSEcCtD
Bisoprolol—Alopecia—Doxorubicin—testicular cancer	0.000545	0.000635	CcSEcCtD
Bisoprolol—Cough—Methotrexate—testicular cancer	0.000541	0.000631	CcSEcCtD
Bisoprolol—Mental disorder—Doxorubicin—testicular cancer	0.000541	0.00063	CcSEcCtD
Bisoprolol—Ill-defined disorder—Epirubicin—testicular cancer	0.000539	0.000628	CcSEcCtD
Bisoprolol—Vomiting—Etoposide—testicular cancer	0.000537	0.000626	CcSEcCtD
Bisoprolol—Erythema—Doxorubicin—testicular cancer	0.000537	0.000626	CcSEcCtD
Bisoprolol—Agitation—Epirubicin—testicular cancer	0.000533	0.000622	CcSEcCtD
Bisoprolol—Rash—Etoposide—testicular cancer	0.000533	0.000621	CcSEcCtD
Bisoprolol—Dermatitis—Etoposide—testicular cancer	0.000532	0.000621	CcSEcCtD
Bisoprolol—Headache—Etoposide—testicular cancer	0.000529	0.000617	CcSEcCtD
Bisoprolol—Arthralgia—Methotrexate—testicular cancer	0.000528	0.000616	CcSEcCtD
Bisoprolol—Chest pain—Methotrexate—testicular cancer	0.000528	0.000616	CcSEcCtD
Bisoprolol—Myalgia—Methotrexate—testicular cancer	0.000528	0.000616	CcSEcCtD
Bisoprolol—Dysgeusia—Doxorubicin—testicular cancer	0.000526	0.000613	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000524	0.000611	CcSEcCtD
Bisoprolol—Malaise—Epirubicin—testicular cancer	0.000523	0.00061	CcSEcCtD
Bisoprolol—Discomfort—Methotrexate—testicular cancer	0.000522	0.000608	CcSEcCtD
Bisoprolol—Vertigo—Epirubicin—testicular cancer	0.000522	0.000608	CcSEcCtD
Bisoprolol—Syncope—Epirubicin—testicular cancer	0.000521	0.000607	CcSEcCtD
Bisoprolol—Back pain—Doxorubicin—testicular cancer	0.00052	0.000606	CcSEcCtD
Bisoprolol—Muscle spasms—Doxorubicin—testicular cancer	0.000516	0.000602	CcSEcCtD
Bisoprolol—Palpitations—Epirubicin—testicular cancer	0.000513	0.000598	CcSEcCtD
Bisoprolol—Confusional state—Methotrexate—testicular cancer	0.00051	0.000595	CcSEcCtD
Bisoprolol—Loss of consciousness—Epirubicin—testicular cancer	0.00051	0.000595	CcSEcCtD
Bisoprolol—Cough—Epirubicin—testicular cancer	0.000507	0.00059	CcSEcCtD
Bisoprolol—Infection—Methotrexate—testicular cancer	0.000503	0.000586	CcSEcCtD
Bisoprolol—Nausea—Etoposide—testicular cancer	0.000502	0.000585	CcSEcCtD
Bisoprolol—Ill-defined disorder—Doxorubicin—testicular cancer	0.000498	0.000581	CcSEcCtD
Bisoprolol—Nervous system disorder—Methotrexate—testicular cancer	0.000496	0.000579	CcSEcCtD
Bisoprolol—Thrombocytopenia—Methotrexate—testicular cancer	0.000496	0.000578	CcSEcCtD
Bisoprolol—Chest pain—Epirubicin—testicular cancer	0.000494	0.000576	CcSEcCtD
Bisoprolol—Arthralgia—Epirubicin—testicular cancer	0.000494	0.000576	CcSEcCtD
Bisoprolol—Myalgia—Epirubicin—testicular cancer	0.000494	0.000576	CcSEcCtD
Bisoprolol—Agitation—Doxorubicin—testicular cancer	0.000494	0.000575	CcSEcCtD
Bisoprolol—Anxiety—Epirubicin—testicular cancer	0.000492	0.000574	CcSEcCtD
Bisoprolol—Skin disorder—Methotrexate—testicular cancer	0.000492	0.000573	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000491	0.000572	CcSEcCtD
Bisoprolol—Hyperhidrosis—Methotrexate—testicular cancer	0.000489	0.00057	CcSEcCtD
Bisoprolol—Discomfort—Epirubicin—testicular cancer	0.000488	0.000569	CcSEcCtD
Bisoprolol—Malaise—Doxorubicin—testicular cancer	0.000484	0.000565	CcSEcCtD
Bisoprolol—Dry mouth—Epirubicin—testicular cancer	0.000483	0.000563	CcSEcCtD
Bisoprolol—Vertigo—Doxorubicin—testicular cancer	0.000483	0.000562	CcSEcCtD
Bisoprolol—Syncope—Doxorubicin—testicular cancer	0.000482	0.000561	CcSEcCtD
Bisoprolol—Confusional state—Epirubicin—testicular cancer	0.000478	0.000557	CcSEcCtD
Bisoprolol—Palpitations—Doxorubicin—testicular cancer	0.000475	0.000553	CcSEcCtD
Bisoprolol—Oedema—Epirubicin—testicular cancer	0.000474	0.000552	CcSEcCtD
Bisoprolol—Hypotension—Methotrexate—testicular cancer	0.000473	0.000551	CcSEcCtD
Bisoprolol—Loss of consciousness—Doxorubicin—testicular cancer	0.000472	0.00055	CcSEcCtD
Bisoprolol—Infection—Epirubicin—testicular cancer	0.000471	0.000549	CcSEcCtD
Bisoprolol—Cough—Doxorubicin—testicular cancer	0.000469	0.000546	CcSEcCtD
Bisoprolol—Shock—Epirubicin—testicular cancer	0.000466	0.000543	CcSEcCtD
Bisoprolol—Nervous system disorder—Epirubicin—testicular cancer	0.000465	0.000542	CcSEcCtD
Bisoprolol—Thrombocytopenia—Epirubicin—testicular cancer	0.000464	0.000541	CcSEcCtD
Bisoprolol—Tachycardia—Epirubicin—testicular cancer	0.000462	0.000539	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000461	0.000538	CcSEcCtD
Bisoprolol—Skin disorder—Epirubicin—testicular cancer	0.00046	0.000536	CcSEcCtD
Bisoprolol—Hyperhidrosis—Epirubicin—testicular cancer	0.000458	0.000534	CcSEcCtD
Bisoprolol—Insomnia—Methotrexate—testicular cancer	0.000458	0.000534	CcSEcCtD
Bisoprolol—Chest pain—Doxorubicin—testicular cancer	0.000457	0.000533	CcSEcCtD
Bisoprolol—Arthralgia—Doxorubicin—testicular cancer	0.000457	0.000533	CcSEcCtD
Bisoprolol—Myalgia—Doxorubicin—testicular cancer	0.000457	0.000533	CcSEcCtD
Bisoprolol—Anxiety—Doxorubicin—testicular cancer	0.000456	0.000531	CcSEcCtD
Bisoprolol—Paraesthesia—Methotrexate—testicular cancer	0.000455	0.00053	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000454	0.000529	CcSEcCtD
Bisoprolol—Discomfort—Doxorubicin—testicular cancer	0.000452	0.000527	CcSEcCtD
Bisoprolol—Dyspnoea—Methotrexate—testicular cancer	0.000451	0.000526	CcSEcCtD
Bisoprolol—Somnolence—Methotrexate—testicular cancer	0.00045	0.000525	CcSEcCtD
Bisoprolol—Dry mouth—Doxorubicin—testicular cancer	0.000447	0.000521	CcSEcCtD
Bisoprolol—Dyspepsia—Methotrexate—testicular cancer	0.000446	0.000519	CcSEcCtD
Bisoprolol—Hypotension—Epirubicin—testicular cancer	0.000443	0.000516	CcSEcCtD
Bisoprolol—Confusional state—Doxorubicin—testicular cancer	0.000442	0.000515	CcSEcCtD
Bisoprolol—Oedema—Doxorubicin—testicular cancer	0.000438	0.000511	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000437	0.000509	CcSEcCtD
Bisoprolol—Fatigue—Methotrexate—testicular cancer	0.000436	0.000509	CcSEcCtD
Bisoprolol—Infection—Doxorubicin—testicular cancer	0.000435	0.000508	CcSEcCtD
Bisoprolol—Pain—Methotrexate—testicular cancer	0.000433	0.000505	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000432	0.000503	CcSEcCtD
Bisoprolol—Shock—Doxorubicin—testicular cancer	0.000431	0.000503	CcSEcCtD
Bisoprolol—Nervous system disorder—Doxorubicin—testicular cancer	0.00043	0.000501	CcSEcCtD
Bisoprolol—Thrombocytopenia—Doxorubicin—testicular cancer	0.000429	0.0005	CcSEcCtD
Bisoprolol—Insomnia—Epirubicin—testicular cancer	0.000428	0.000499	CcSEcCtD
Bisoprolol—Tachycardia—Doxorubicin—testicular cancer	0.000428	0.000499	CcSEcCtD
Bisoprolol—Skin disorder—Doxorubicin—testicular cancer	0.000426	0.000496	CcSEcCtD
Bisoprolol—Paraesthesia—Epirubicin—testicular cancer	0.000425	0.000496	CcSEcCtD
Bisoprolol—Hyperhidrosis—Doxorubicin—testicular cancer	0.000424	0.000494	CcSEcCtD
Bisoprolol—Dyspnoea—Epirubicin—testicular cancer	0.000422	0.000492	CcSEcCtD
Bisoprolol—Somnolence—Epirubicin—testicular cancer	0.000421	0.000491	CcSEcCtD
Bisoprolol—Feeling abnormal—Methotrexate—testicular cancer	0.000417	0.000486	CcSEcCtD
Bisoprolol—Dyspepsia—Epirubicin—testicular cancer	0.000417	0.000486	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Methotrexate—testicular cancer	0.000414	0.000483	CcSEcCtD
Bisoprolol—Hypotension—Doxorubicin—testicular cancer	0.00041	0.000477	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000409	0.000477	CcSEcCtD
Bisoprolol—Fatigue—Epirubicin—testicular cancer	0.000408	0.000476	CcSEcCtD
Bisoprolol—Pain—Epirubicin—testicular cancer	0.000405	0.000472	CcSEcCtD
Bisoprolol—Constipation—Epirubicin—testicular cancer	0.000405	0.000472	CcSEcCtD
Bisoprolol—Urticaria—Methotrexate—testicular cancer	0.000402	0.000469	CcSEcCtD
Bisoprolol—Body temperature increased—Methotrexate—testicular cancer	0.0004	0.000466	CcSEcCtD
Bisoprolol—Abdominal pain—Methotrexate—testicular cancer	0.0004	0.000466	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000399	0.000466	CcSEcCtD
Bisoprolol—Insomnia—Doxorubicin—testicular cancer	0.000396	0.000462	CcSEcCtD
Bisoprolol—Paraesthesia—Doxorubicin—testicular cancer	0.000394	0.000459	CcSEcCtD
Bisoprolol—Dyspnoea—Doxorubicin—testicular cancer	0.000391	0.000456	CcSEcCtD
Bisoprolol—Feeling abnormal—Epirubicin—testicular cancer	0.00039	0.000455	CcSEcCtD
Bisoprolol—Somnolence—Doxorubicin—testicular cancer	0.00039	0.000454	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Epirubicin—testicular cancer	0.000387	0.000452	CcSEcCtD
Bisoprolol—Dyspepsia—Doxorubicin—testicular cancer	0.000386	0.00045	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000378	0.000441	CcSEcCtD
Bisoprolol—Fatigue—Doxorubicin—testicular cancer	0.000378	0.000441	CcSEcCtD
Bisoprolol—Urticaria—Epirubicin—testicular cancer	0.000376	0.000439	CcSEcCtD
Bisoprolol—Pain—Doxorubicin—testicular cancer	0.000375	0.000437	CcSEcCtD
Bisoprolol—Constipation—Doxorubicin—testicular cancer	0.000375	0.000437	CcSEcCtD
Bisoprolol—Body temperature increased—Epirubicin—testicular cancer	0.000375	0.000437	CcSEcCtD
Bisoprolol—Abdominal pain—Epirubicin—testicular cancer	0.000375	0.000437	CcSEcCtD
Bisoprolol—Hypersensitivity—Methotrexate—testicular cancer	0.000373	0.000435	CcSEcCtD
Bisoprolol—Asthenia—Methotrexate—testicular cancer	0.000363	0.000423	CcSEcCtD
Bisoprolol—Feeling abnormal—Doxorubicin—testicular cancer	0.000361	0.000421	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000358	0.000418	CcSEcCtD
Bisoprolol—Pruritus—Methotrexate—testicular cancer	0.000358	0.000417	CcSEcCtD
Bisoprolol—Hypersensitivity—Epirubicin—testicular cancer	0.000349	0.000407	CcSEcCtD
Bisoprolol—Urticaria—Doxorubicin—testicular cancer	0.000348	0.000406	CcSEcCtD
Bisoprolol—Body temperature increased—Doxorubicin—testicular cancer	0.000347	0.000404	CcSEcCtD
Bisoprolol—Abdominal pain—Doxorubicin—testicular cancer	0.000347	0.000404	CcSEcCtD
Bisoprolol—Diarrhoea—Methotrexate—testicular cancer	0.000346	0.000404	CcSEcCtD
Bisoprolol—Asthenia—Epirubicin—testicular cancer	0.00034	0.000396	CcSEcCtD
Bisoprolol—Pruritus—Epirubicin—testicular cancer	0.000335	0.000391	CcSEcCtD
Bisoprolol—Dizziness—Methotrexate—testicular cancer	0.000335	0.00039	CcSEcCtD
Bisoprolol—Diarrhoea—Epirubicin—testicular cancer	0.000324	0.000378	CcSEcCtD
Bisoprolol—Hypersensitivity—Doxorubicin—testicular cancer	0.000323	0.000376	CcSEcCtD
Bisoprolol—Vomiting—Methotrexate—testicular cancer	0.000322	0.000375	CcSEcCtD
Bisoprolol—Rash—Methotrexate—testicular cancer	0.000319	0.000372	CcSEcCtD
Bisoprolol—Dermatitis—Methotrexate—testicular cancer	0.000319	0.000372	CcSEcCtD
Bisoprolol—Headache—Methotrexate—testicular cancer	0.000317	0.00037	CcSEcCtD
Bisoprolol—Asthenia—Doxorubicin—testicular cancer	0.000315	0.000367	CcSEcCtD
Bisoprolol—Dizziness—Epirubicin—testicular cancer	0.000313	0.000365	CcSEcCtD
Bisoprolol—Pruritus—Doxorubicin—testicular cancer	0.00031	0.000361	CcSEcCtD
Bisoprolol—Vomiting—Epirubicin—testicular cancer	0.000301	0.000351	CcSEcCtD
Bisoprolol—Nausea—Methotrexate—testicular cancer	0.000301	0.00035	CcSEcCtD
Bisoprolol—Diarrhoea—Doxorubicin—testicular cancer	0.0003	0.00035	CcSEcCtD
Bisoprolol—Rash—Epirubicin—testicular cancer	0.000299	0.000348	CcSEcCtD
Bisoprolol—Dermatitis—Epirubicin—testicular cancer	0.000298	0.000348	CcSEcCtD
Bisoprolol—Headache—Epirubicin—testicular cancer	0.000297	0.000346	CcSEcCtD
Bisoprolol—Dizziness—Doxorubicin—testicular cancer	0.00029	0.000338	CcSEcCtD
Bisoprolol—Nausea—Epirubicin—testicular cancer	0.000281	0.000328	CcSEcCtD
Bisoprolol—Vomiting—Doxorubicin—testicular cancer	0.000279	0.000325	CcSEcCtD
Bisoprolol—Rash—Doxorubicin—testicular cancer	0.000276	0.000322	CcSEcCtD
Bisoprolol—Dermatitis—Doxorubicin—testicular cancer	0.000276	0.000322	CcSEcCtD
Bisoprolol—Headache—Doxorubicin—testicular cancer	0.000275	0.00032	CcSEcCtD
Bisoprolol—Nausea—Doxorubicin—testicular cancer	0.00026	0.000303	CcSEcCtD
